ATE114049T1 - Bestätigender nachweis für chlamydia trachomatis. - Google Patents

Bestätigender nachweis für chlamydia trachomatis.

Info

Publication number
ATE114049T1
ATE114049T1 AT89113783T AT89113783T ATE114049T1 AT E114049 T1 ATE114049 T1 AT E114049T1 AT 89113783 T AT89113783 T AT 89113783T AT 89113783 T AT89113783 T AT 89113783T AT E114049 T1 ATE114049 T1 AT E114049T1
Authority
AT
Austria
Prior art keywords
organism
ligand
dbp
signal
cbp
Prior art date
Application number
AT89113783T
Other languages
English (en)
Inventor
Lawrence Vaughan Howard Jr
Marycaren Craine
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE114049T1 publication Critical patent/ATE114049T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Dental Preparations (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT89113783T 1988-08-04 1989-07-26 Bestätigender nachweis für chlamydia trachomatis. ATE114049T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/228,363 US5064755A (en) 1988-08-04 1988-08-04 Two-site confirmatory assay

Publications (1)

Publication Number Publication Date
ATE114049T1 true ATE114049T1 (de) 1994-11-15

Family

ID=22856875

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89113783T ATE114049T1 (de) 1988-08-04 1989-07-26 Bestätigender nachweis für chlamydia trachomatis.

Country Status (8)

Country Link
US (1) US5064755A (de)
EP (1) EP0353614B1 (de)
JP (1) JP2812995B2 (de)
KR (1) KR900003630A (de)
AT (1) ATE114049T1 (de)
AU (1) AU620126B2 (de)
CA (1) CA1339769C (de)
DE (1) DE68919294T2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212075A (en) * 1991-04-15 1993-05-18 The Regents Of The University Of California Compositions and methods for introducing effectors to pathogens and cells
US5916757A (en) * 1994-05-31 1999-06-29 Johnson & Johnson Clinical Diagnostics, Inc. Specific binding assay using enzyme inhibitor and anti-inhibitor antibodies
US5565326A (en) * 1994-05-31 1996-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Separation-free specific binding assays using anti-inhibitor antibodies
WO1999037798A1 (en) * 1998-01-27 1999-07-29 Scantibodies Laboratory, Inc. Methods for detecting false negative results in blood screening assays using a single aliquot elevated baseline as an internal assay control
US6306616B1 (en) 1998-03-27 2001-10-23 Microgenics Corporation Adsorption type confirmatory assays
EP1066523A2 (de) * 1998-03-27 2001-01-10 Microgenics Corporation Kontrollbestimmungsmethoden für drogen bestehend aus kleinen molekülen
US20140057296A1 (en) * 2011-03-01 2014-02-27 Shire Human Genetic Therapies, Inc. Assays for antibodies which bind to therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
US4737456A (en) * 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US4818688A (en) * 1986-11-21 1989-04-04 E. I. Du Pont De Nemours And Company Assays for antibody to hepatitis B core antigen
ATE78598T1 (de) * 1987-01-21 1992-08-15 Abbott Lab Immunassay unter benutzung der mikropartikelneutralisierung.

Also Published As

Publication number Publication date
AU620126B2 (en) 1992-02-13
DE68919294D1 (de) 1994-12-15
DE68919294T2 (de) 1995-06-14
AU3927989A (en) 1990-02-08
EP0353614A3 (en) 1990-11-14
JPH02112764A (ja) 1990-04-25
JP2812995B2 (ja) 1998-10-22
EP0353614B1 (de) 1994-11-09
KR900003630A (ko) 1990-03-26
CA1339769C (en) 1998-03-24
EP0353614A2 (de) 1990-02-07
US5064755A (en) 1991-11-12

Similar Documents

Publication Publication Date Title
DE69233724D1 (de) Bindungsdomänen des Serrate-Proteins
CA2007532A1 (en) Threshold ligand-receptor assay
ATE297554T1 (de) Verfahren zur besserung der wiederfindung troponin i und t
ATE228247T1 (de) Testreagentien und testvorrichtungen
GR3005303T3 (de)
DE3854496D1 (de) Peptide und antikörper, die die bindung von blutplättchen verhindern.
IL76412A0 (en) Carrier for immune assay
DE69433114D1 (de) Metallion-ligand koordinationskomplexe, antikorper dagegen und tests die solche antikorper verwenden
EP0496473A3 (en) Method of preparing biologically active reagents from succinimide-containing polymers, analytical element and methods of use
GR3036138T3 (en) A screening method for identifying ligands for target proteins
ES2141086T3 (es) Anticuerpos contra los ligando-analogos y su uso en los dosificados ligando-receptores.
FR2662804B1 (fr) Anticorps polyclonaux anti-lh et leurs applications a la detection et/ou au dosage de la lh, chez de multiples especes animales.
NL181461C (nl) Werkwijze en reagenskit voor het bepalen van antigenen, antilichamen of antigeen-antilichaam-complexen of -conjugaten.
ATE114049T1 (de) Bestätigender nachweis für chlamydia trachomatis.
DE59107797D1 (de) Verfahren zum Nachweis von phosphoryliertes Tyrosin enthaltenden Proteinen
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
ES8707342A1 (es) Un metodo de medida de la concentracion de un ligando libre en un fluido biologico
EP0535347A3 (en) Monoclonal antibodies to sulfonated polymers
CA2081879A1 (en) Monoclonal antibodies to polyacrylate polymers
ES2002578A6 (es) Procedimiento para obtener reactivos diagnosticos
RU95114865A (ru) Способ агглютинационного иммунологического анализа при помощи дисперсного препарата на основе оксида железа (iii)
ATE171545T1 (de) Verfahren zur bestimmung des lysingehaltes von samen
FI875475A7 (fi) Hiiren hybridoma Lym-1 ja sillä tuotettu diagnostinen vasta-aine.
BR8401257A (pt) Reagente sorologico caracterizado pela acao combinada de substancias inibidoras de fatores lectinosimilares ou anticorpos inespecificos e substancias detectoras de antigenos e anticorpos especificos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties